You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PENTAM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Pentam, and what generic alternatives are available?

Pentam is a drug marketed by Fresenius Kabi Usa, Seton Pharms, X-gen Pharms Inc, Avet Lifesciences, Baxter Hlthcare, Hospira, Watson Labs, and Xgen Pharms. and is included in nine NDAs.

The generic ingredient in PENTAM is pentamidine isethionate. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the pentamidine isethionate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pentam

A generic version of PENTAM was approved as pentamidine isethionate by SETON PHARMS on September 28th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PENTAM?
  • What are the global sales for PENTAM?
  • What is Average Wholesale Price for PENTAM?
Drug patent expirations by year for PENTAM
Drug Prices for PENTAM

See drug prices for PENTAM

Recent Clinical Trials for PENTAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Illinois at Chicago

See all PENTAM clinical trials

Pharmacology for PENTAM
Drug ClassAntiprotozoal

US Patents and Regulatory Information for PENTAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa PENTAM pentamidine isethionate INJECTABLE;INJECTION 019264-001 Oct 16, 1984 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Seton Pharms PENTAMIDINE ISETHIONATE pentamidine isethionate INJECTABLE;INJECTION 206666-001 Sep 28, 2017 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Avet Lifesciences PENTAMIDINE ISETHIONATE pentamidine isethionate INJECTABLE;INJECTION 213806-001 Jan 7, 2021 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.